A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
A coalition of 18 state Attorneys General has sent a letter to Congressional leadership, urging further investigation into ...
Fauci worked in the federal government for decades before rising to prominence as the public face of the government’s ...
A recent paper published in Science magazine by researcher Blanca Barquera, Ph.D., professor of biological sciences at ...
The letter seeks information from Senate and House committees that have investigated the issue or have launched ...
There's widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and ...
The trial will be sponsored and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH). The FDA’s action is a critical first step ...
Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...